Tristel plc (FRA:R1V)

Market Cap	204.58M +10.6%
Revenue (ttm)	56.78M +13.7%
Net Income	9.01M +28.1%
EPS	0.19 +26.1%
Shares Out	n/a
PE Ratio	22.69
Forward PE	21.57
Dividend	0.16 (3.86%)
Ex-Dividend Date	Mar 19, 2026

Volume	n/a
Average Volume	161
Open	4.220
Previous Close	4.220
Day's Range	4.220 - 4.220
52-Week Range	3.040 - 5.050
Beta	n/a
RSI	37.61
Earnings Date	Mar 2, 2026

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 1993
• Employees: 270
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: R1V

Financial Performance

In fiscal year 2025, Tristel's revenue was 46.46 million, an increase of 10.80% compared to the previous year's 41.93 million. Earnings were 6.64 million, an increase of 2.33%.

Financial numbers in GBP